| Tunable recombinant protein expression in E. coli: promoter systems and genetic constraints L Marschall, P Sagmeister, C Herwig Applied microbiology and biotechnology 101, 501-512, 2017 | 62 | 2017 |
| Tunable recombinant protein expression in E. coli: enabler for continuous processing? L Marschall, P Sagmeister, C Herwig Applied microbiology and biotechnology 100, 5719-5728, 2016 | 44 | 2016 |
| Simple monitoring of cell leakiness and viability in Escherichia coli bioprocesses—A case study DJ Wurm, L Marschall, P Sagmeister, C Herwig, O Spadiut Engineering in Life Sciences 17 (6), 598-604, 2017 | 14 | 2017 |
| Integrated process model applications linking bioprocess development to quality by design milestones C Taylor, L Marschall, M Kunzelmann, M Richter, F Rudolph, J Vajda, ... Bioengineering 8 (11), 156, 2021 | 11 | 2021 |
| Workflow for criticality assessment applied in biopharmaceutical process validation stage 1 T Zahel, L Marschall, S Abad, E Vasilieva, D Maurer, EM Mueller, ... Bioengineering 4 (4), 85, 2017 | 11 | 2017 |
| Specification-driven acceptance criteria for validation of biopharmaceutical processes L Marschall, C Taylor, T Zahel, M Kunzelmann, A Wiedenmann, B Presser, ... Frontiers in Bioengineering and Biotechnology 10, 1010583, 2022 | 2 | 2022 |
| Temperature Upshifts in Mammalian Cell Culture: A Suitable Strategy for Biosimilar Monoclonal Antibodies? L Marschall, CB Gottimukkala, B Kayal, VM Veeraraghavan, SK Mandal, ... Bioengineering 10 (10), 1149, 2023 | | 2023 |
| Expression tuning in E. coli: discussion of state-of-the-art technologies and multivariate investigation of the pBAD mixed feed system L Marschall Wien, 2016 | | 2016 |
